The Chemours Company (CC) Stock Overview
Explore The Chemours Company’s financial performance, market position, analyst ratings, and future outlook.
The Chemours Company (CC)
Key Financials
Key Financials
Market Cap
2.6B
P/E Ratio
-6.37
EPS (TTM)
$0.88
ROE
-1.64%
CC Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of The Chemours Company (CC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 34.74, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $21.67.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -6.37 and a market capitalization of 2.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.